- This summary was generated by AI from multiple online sources. Find the source links used for this summary under "Based on sources".
Learn more about Bing search results hereAnti-cancer medicationOrganizing and summarizing search results for you1mghttps://www.1mg.com/generics/gefitinib-209939Gefitinib: View Uses, Side Effects and Medicines | 1mgGefitinib is used in the treatment of non-small cell lung cancer. It is used in patients in which it has spread to other parts of the body, who have abnormal epidermal growth facto…DrugBankhttps://go.drugbank.com/drugs/DB00317Gefitinib: Uses, Interactions, Mechanism of Action | DrugBank OnlineGefitinib is an inhibitor of the epidermal growth factor receptor (EGFR) tyrosine kinase that binds to the adenosine triphosphate (ATP)-binding site of the enzyme. EGFR is often sh… - See more
See all on WikipediaGefitinib - Wikipedia
Gefitinib, sold under the brand name Iressa, is a medication used for certain breast, lung and other cancers. Gefitinib is an EGFR inhibitor, like erlotinib, which interrupts signaling through the epidermal growth factor receptor (EGFR) in target cells. Therefore, it is only effective in cancers with mutated and … See more
Gefitinib is the first selective inhibitor of epidermal growth factor receptor's (EGFR) tyrosine kinase domain. Thus gefitinib is an EGFR inhibitor. The target protein (EGFR) is a member … See more
In August 2013, the BBC reported that researchers in Edinburgh and Melbourne found, in a small-scale trial of 12 patients, that the effectiveness of Methotrexate for treating ectopic pregnancy was improved when Gefitinib was also administered. See more
Gefitinib is marketed in many countries.
Iressa was approved and marketed in July 2002, in Japan, making it the first country to import the drug.
The FDA approved … See moreIPASS (IRESSA Pan-Asia Study) was a randomized, large-scale, double-blinded study which compared gefitinib vs. carboplatin/ paclitaxel as a first-line treatment in … See more
Gefitinib and other first-generation EGFR inhibitors reversibly bind to the receptor protein, effectively competing for the ATP binding pocket. Secondary mutations can arise that alter the … See more
Wikipedia text under CC-BY-SA license Gefitinib Uses, Side Effects & Warnings - Drugs.com
Gefitinib is a cancer medication that interferes with the growth and spread of cancer cells in the body. It is used to treat non-small cell lung cancer with certain EGFR mu…
- 8.9/10(8)
- Estimated Reading Time: 5 mins
Gefitinib
Common brand names: IressaGefitinib is used to treat lung cancer.
May Treat: Metastatic NSCLC with EGFR exon 19 deletion · Metastatic NSCLC with EGFR exon 21 L858R substitution
Brand Names: Iressa
Drug Class: Antineoplastic - 1st generation EGFR tyrosine kinase inhibitor
Availability: Prescription Required
Pregnancy: Consult your doctor. This medication may be harmful to an unborn child.
Lactation: This drug should not be given to breastfeeding mothers
PrecautionsFor informational purposes only. Consult a medical professional for advice.
Source: First Databank Learn more
Gefitinib (oral route) - Mayo Clinic
Sep 13, 2015 · Gefitinib is used to treat metastatic (cancer that has already spread) non-small cell lung cancer in patients who have certain types of abnormal epidermal growth factor (EGFR) …
Gefitinib: Uses, Interactions, Mechanism of Action - DrugBank Online
679 rows · Gefitinib is an inhibitor of the epidermal growth factor receptor (EGFR) tyrosine …
See all 679 rows on go.drugbank.comDRUG INTERACTION Abametapir The serum concentration of Gefitinib can ... Abatacept The metabolism of Gefitinib can be ... Abemaciclib Gefitinib may decrease the excretion rate ... Abiraterone The metabolism of Gefitinib can be ...
Gefitinib - NCI - National Cancer Institute
Gefitinib is a drug approved to treat metastatic non-small cell lung cancer with certain EGFR gene mutations. Learn more about its definition, side effects, interactions, and ongoing studies of …
Gefitinib Oral: Uses, Side Effects, Interactions, Pictures …
Gefitinib is used to treat lung cancer. It works by slowing or stopping the growth of cancer cells. Gefitinib blocks a certain protein (an enzyme called tyrosine kinase).
- People also ask
Gefitinib (Iressa) | Cancer information | Cancer Research UK
Gefitinib is a type of targeted cancer drug. You pronounce it as jeh-fit-ih-nib. It is also known as Iressa. It is a treatment for non small cell lung cancer (NSCLC) that has spread into the …
Gefitinib: MedlinePlus Drug Information
Gefitinib is a kinase inhibitor used to treat non-small cell lung cancer that has spread to other parts of the body. Learn how to take it, what interactions and precautions to follow, and what to …
Gefitinib - targeted therapy drug to treat NSCLC
Gefitinib belongs to a group of targeted therapy drugs known as cancer growth inhibitors. It is used to treat non-small cell lung cancer (NSCLC) that has started to spread to: surrounding …
Gefitinib (an EGFR tyrosine kinase inhibitor) plus …
Aug 13, 2024 · Dual inhibition of vascular endothelial growth factor and epidermal growth factor receptor (EGFR) signaling pathways offers the prospect of improving the effectiveness of EFGR-targeted therapy.
Skip to content
